Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LAB · against 1,372 other Healthcare companies
Ranked #257 of 1,373 · scores higher than 81% of peers · safety percentile 81
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including LAB · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | LAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.05× | 0.24× | 75% | 33% | |
| BetaLower is better · 1,320 reported | 1.35 | 0.53 | 14% | 33% | |
| Current ratioHigher is better · 1,338 reported | 9.10× | 2.62× | 86% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 253 | 298M CHF (≈$342M) | 82 | 74 | |
| 254 | 97.3B INR (≈$1.2B) | 82 | 80 | |
| 255 | 2.8B CNY (≈$396M) | 81 | 29 | |
| 256 | 3.0B CNY (≈$415M) | 81 | 55 | |
| 257 | 239M USD | 81 | 38 | |
| 258 | 6.8B CNY (≈$950M) | 81 | 80 | |
| 259 | 418M USD | 81 | 74 | |
| 260 | 22M USD | 81 | 47 | |
| 261 | 4.25T INR (≈$51.0B) | 81 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score